A study to improve the pain management, early recovery and less hospital stay after caesarean delivery

A prospective randomised controlled trial to study the benefit of Enhanced Recovery After Surgery (ERAS) adoption in acute pain management after elective caesarean delivery. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070886

Enrollment

100

Registered

2024-07-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: ERAS PROTOCOL FOR CAESAREN SECTION,: Bilateral TAP block with total 40mLs of Ropivacaine 0.5%, with 2 mLs of 8mg Decadron. Inj. Granisetron 3mg just before incision. Control Interventi

Eligibility

Inclusion criteria

Inclusion criteria: Parturient scheduled for planned Caesarean delivery ASA grades I and II

Exclusion criteria

Exclusion criteria: Hypotension /Hypertension Obesity Fetal compromise Preterm gestation Coagulopathies Maternal age less than 25 years Allergy to study agents Contraindications to TAP block, Refusal to participate in the study

Design outcomes

Primary

Measure	Time frame
Post operative pain intensity and decrease in opioid consumptionTimepoint: At 24th hour and 48 hours from the time of incision.	—

Secondary

Measure	Time frame
Perioperative discomfort, satisfaction score,length of stay, hospitalization cost.Timepoint: At 24th & 48th hour after incision,at the time of discharge from hospital	—

Countries

India

Contacts

Public ContactShivanand Karigar

Shri B M Patil Medical College and hospital

shivanandkarigar82@gmail.com9164319345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026